Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 40 abstracts across nine blood disorders at the 66th American Society of Hematology ...

The slogan of the TB research group I work for is “Every breath counts”. This is something I truly believe. Every breath we take matters. But somehow the soft, gentle breaths of the youngest ...

Even in cases where breath is particularly foul-smelling, oral care experts that we spoke to assured us that over-the-counter solutions exist, even when you’ve given up hope. St. Louis, Missouri-based ...

b) in Dhaka. At a time when diarrhoeal diseases claimed lives of one in five children in Bangladesh, Cash co-developed Oral Rehydration Therapy (ORT), a breakthrough treatment that has saved ...

(NASDAQ: IBRX), announced today that the first patients have been dosed in an initial trial studying the potential of the company’s CAR-NK cell therapy targeting CD-19 in the treatment of non ...

“It is true that some Bollywood actresses are headlining Telugu films these days, and they come as a breath of fresh air ... Hanu Raghuvapudi introduced B-town diva Mrunal Thakur in his ...

Breath of Fire, a four-part docuseries based on the life of Guru Jagat, premiered on HBO on October 23, 2024. Hayley Pappas and Smiley Stevens have directed the docuseries which is based on Hayley ...

Be Bio’s BE-101 works by inserting the human Factor IX (FIX) gene into primary human B cells. Image credit: Shutterstock/ ardhikauw. Be Biopharma has raised $82m in financing to advance a gene therapy ...

Hyperbaric oxygen therapy (HBOT) is one non-drug treatment that has been proposed for helping manage chronic pain. The descriptions of HBOT that are provided by some clinics make it sound like a ...

With an upfront payment of $50 million from Roche, the partnership will leverage Dyno Therapeutics’ in vivo gene therapy delivery technology, which synthesizes virus capsids with better functionality ...

Company’s first clinical trial studying CAR-NK (CD19 t-haNK) cellular therapy in liquid tumors First natural killer cell-based cellular ... in participants with selected CD19+ and CD20+ ...